What is the treatment for hypoventilation syndrome?

What is the treatment for hypoventilation syndrome?

Bronchodilators, such as beta agonists (eg, albuterol, salmeterol), anticholinergic agents (eg, ipratropium bromide), and methylxanthines (eg, theophylline), are helpful in treating patients with obstructive lung disease and severe bronchospasm.

How is hypoventilation syndrome diagnosed?

Diagnosis is usually made by the clinician’s awareness that alveolar hypoventilation is often associated with certain medical disorders. Investigations include arterial blood gas analysis, pulmonary function tests, measurement of respiratory muscle strength, and an overnight polysomnogram.

What is the difference between OSA and Ohs?

The classic features of obesity hypoventilation syndrome (OHS) are obesity and daytime hypercapnia. The differences between OHS and obstructive sleep apnoea (OSA) are that the former has: Longer and more continuous episodes of hypoventilation overnight (there may or may not be upper airway obstruction).

Can obesity hypoventilation syndrome be cured?

How is OHS treated? Treatment for OHS will include weight loss and treating your sleep-related breathing disorder. Sometimes, weight loss alone corrects many of the symptoms and problems such as obstructive sleep apnea. Therefore, the first approach to treating your OHS is weight loss.

What are the signs and symptoms of hypoventilation?

Symptoms

• Bluish coloration of the skin caused by lack of oxygen.
• Daytime drowsiness.
• Fatigue.
• Morning headaches.
• Swelling of the ankles.
• Waking up from sleep unrested.
• Waking up many times at night.

What is the result of hypoventilation?

Hypoventilation is breathing that is too shallow or too slow to meet the needs of the body. If a person hypoventilates, the body’s carbon dioxide level rises. This causes a buildup of acid and too little oxygen in the blood. A person with hypoventilation might feel sleepy.

How is obesity hypoventilation syndrome ( OHS ) defined?

Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass index ≥30 kg·m -2 ), daytime hypercapnia (arterial carbon dioxide tension ≥45 mmHg) and sleep disordered breathing, after ruling out other disorders that may cause alveolar hypoventilation. OHS prevalence has been estimated to be ∼0.4% of the adult population.

How is obesity hypoventilation syndrome related to REM sleep?

The repetitive occurrence of hypoventilation, initially limited to REM sleep, induces a secondary depression of respiratory centres leading to daytime hypercapnia and obesity hypoventilation syndrome [ 4 ].

Are there any patients with non obstructive sleep hypoventilation?

The remaining patients have non-obstructive sleep hypoventilation with no or mild OSA.

When does alveolar hypoventilation lead to hypoxia?

During sleep, alveolar hypoventilation leads to nocturnal hypercapnia and hypoxia, which over time leads to resetting of the chemostat of the respiratory controller and consequent daytime hypercapnia and hypoxemia. The hypercapnia of OHS may be augmented by Leptin resistance.